Zobrazeno 1 - 5
of 5
pro vyhledávání: '"Reto A. Rapold"'
Publikováno v:
Journal of Lipid Research, Vol 54, Iss 1, Pp 63-70 (2013)
Fas (CD95) is a member of the tumor necrosis factor (TNF) receptor superfamily and plays a crucial role in the induction of apoptosis. However, like TNF, Fas can induce nonapoptotic signaling pathways. We previously demonstrated that mice lacking Fas
Externí odkaz:
https://doaj.org/article/31cf8dc88b374c70abb0e9710ff461e3
Autor:
Marc Y. Donath, Alexander V. Chervonsky, Desiree M. Schumann, Daniel Konrad, Julia M. Rytka, Anita Schildknecht, Eugen J. Schoenle, Reto A. Rapold, Ori Nov, Assaf Rudich, Stephan Wueest
Publikováno v:
Journal of Clinical Investigation. 120:191-202
Adipose tissue inflammation is linked to the pathogenesis of insulin resistance. In addition to exerting death-promoting effects, the death receptor Fas (also known as CD95) can activate inflammatory pathways in several cell lines and tissues, althou
Autor:
Daniel Konrad, Rowayda Peters, Stefanie Regine Dannenmann, Adriano Aguzzi, Monika Julia Wolf, Joseph R. Bertino, Reto A. Rapold, Maries van den Broek, Bruno Stieger, Mario Nuvolone, A. Rubin, Alexander Knuth, Mathias Heikenwalder
Publikováno v:
PLoS ONE
PLoS ONE, Vol 5, Iss 12, p e15689 (2010)
PLoS ONE 5:e15689 (2010)
PLoS ONE, Vol 5, Iss 12, p e15689 (2010)
PLoS ONE 5:e15689 (2010)
BACKGROUND: Haematopoiesis is sustained by haematopoietic (HSC) and mesenchymal stem cells (MSC). HSC are the precursors for blood cells, whereas marrow, stroma, bone, cartilage, muscle and connective tissues derive from MSC. The generation of MSC fr
Publikováno v:
FEBS letters
Fas (CD95) belongs to the superfamily of the tumor necrosis factor (TNF) receptors. Besides its key role in apoptosis, Fas contributes to non-apoptotic pathways such as cell proliferation and inflammation. In 3T3-L1 adipocytes, activation of Fas by F
Publikováno v:
Diabetologia
AIMS/HYPOTHESIS Adipocytes in obesity are characterised by increased cell size and insulin resistance compared with adipocytes isolated from lean patients. However it is not clear at present whether hypertrophy actually does drive adipocyte insulin r
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::f975aead98fdad022e13f0bbba4b4170